Respiratory impairment in multiple sclerosis: a study of respiratory function in wheelchair-bound patients

European Journal of Neurology

Volumn 24, Issue 3, 2017, Pages 497-502

  Levy, J ^a,b   Bensmail, D ^a,b   Brotier Chomienne, A ^a   Butel, S ^a   Joussain, C ^a,b   Hugeron, C ^a   Prigent, H ^a,b  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

cough assistance; multiple sclerosis; non invasive ventilation; pulmonary function test; rehabilitation; respiratory failure

Indexed keywords

ADULT; ARTICLE; BREATHING MUSCLE; CLINICAL OUTCOME; COUGHING; DIAPHRAGM; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; HYPERCAPNIA; LIMITED MOBILITY; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NONINVASIVE VENTILATION; OBSERVATIONAL STUDY; PRESSURE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; RETROSPECTIVE STUDY; SLEEP DISORDERED BREATHING; VITAL CAPACITY; AGED; COMPLICATION; DISABILITY; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; SLEEP DISORDER; WHEELCHAIR;

AGED; COUGH; DISABILITY EVALUATION; FEMALE; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYSOMNOGRAPHY; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; RESPIRATORY MUSCLES; SLEEP WAKE DISORDERS; VITAL CAPACITY; WHEELCHAIRS;

EID: 85010508362     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.13231     Document Type: Article

References (37)

1. Kamm CP, Uitdehaag BM, Polman CH. Multiple sclerosis: current knowledge and future outlook. Eur Neurol 2014; 72: 132–141.
2. Tzelepis GE, McCool FD. Respiratory dysfunction in multiple sclerosis. Respir Med 2015; 109: 671–679.
3. Altintas A, Demir T, Ikitimur HD, Yildirim N. Pulmonary function in multiple sclerosis without any respiratory complaints. Clin Neurol Neurosurg 2007; 109: 242–246.
4. Ray AD, Mahoney MC, Fisher NM. Measures of respiratory function correlate with fatigue in ambulatory persons with multiple sclerosis. Disabil Rehabil 2015; 37: 2407–2412.
5. Hirst C, Swingler R, Compston DAS, Ben-Shlomo Y, Robertson NP. Survival and cause of death in multiple sclerosis: a prospective population-based study. J Neurol Neurosurg Psychiatry 2008; 79: 1016–1021.
6. Gosselink R, Kovacs L, Decramer M. Respiratory muscle involvement in multiple sclerosis. Eur Respir J 1999; 13: 449–454.
7. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.
8. Laszlo G. Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax 2006; 61: 744–746.
9. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of lung function testing: the authors’ replies to readers’ comments. Eur Respir J 2010; 36: 1496–1498.
10. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324–1343.
11. Héritier F, Rahm F, Pasche P, Fitting JW. Sniff nasal inspiratory pressure. A noninvasive assessment of inspiratory muscle strength. Am J Respir Crit Care Med 1994; 150: 1678–1683.
12. Evans JA, Whitelaw WA. The assessment of maximal respiratory mouth pressures in adults. Respir Care 2009; 54: 1348–1359.
13. Bach JR, Ishikawa Y, Kim H. Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest 1997; 112: 1024–1028.
14. Bach JR. Amyotrophic lateral sclerosis: predictors for prolongation of life by noninvasive respiratory aids. Arch Phys Med Rehabil 1995; 76: 828–832.
15. Riha RL. Diagnostic approaches to respiratory sleep disorders. J Thorac Dis 2015; 7: 1373–1384.
16. Srour N, LeBlanc C, King J, McKim DA. Lung volume recruitment in multiple sclerosis. PLoS ONE 2013; 8: e56676.
17. Gosselink R, Kovacs L, Ketelaer P, Carton H, Decramer M. Respiratory muscle weakness and respiratory muscle training in severely disabled multiple sclerosis patients. Arch Phys Med Rehabil 2000; 81: 747–751.
18. Smeltzer SC, Lavietes MH, Cook SD. Expiratory training in multiple sclerosis. Arch Phys Med Rehabil 1996; 77: 909–912.
19. Fromageot C, Lofaso F, Annane D, et al. Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders. Arch Phys Med Rehabil 2001; 82: 123–128.
20. Lechtzin N, Wiener CM, Shade DM, Clawson L, Diette GB. Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis. Chest 2002; 121: 436–442.
21. Trebbia G, Lacombe M, Fermanian C, et al. Cough determinants in patients with neuromuscular disease. Respir Physiol Neurobiol 2005; 146: 291–300.
22. Make BJ, Hill NS, Goldberg AI, et al. Mechanical ventilation beyond the intensive care unit: report of a consensus conference of the American College of Chest Physicians. Chest 1998; 113: S289.
23. Windisch W, Walterspacher S, Siemon K, Geiseler J, Sitter H. Guidelines for non-invasive and invasive mechanical ventilation for treatment of chronic respiratory failure. Pneumologie 2010; 64: 640–652.
24. Finder JD, Birnkrant D, Carl J, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 2004; 170: 456–465.
25. EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, Andersen PM, Abrahams S, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) - revised report of an EFNS task force. Eur J Neurol 2012; 19: 360–375.
26. Pittock SJ. Mechanical ventilation and tracheostomy in multiple sclerosis. J Neurol Neurosurg Psychiatry 2004; 75: 1331–1333.
27. Howard RS, Wiles CM, Hirsch NP, Loh L, Spencer GT, Newsom-Davis J. Respiratory involvement in multiple sclerosis. Brain 1992; 115: 479–494.
28. Ghose K, Holmes KM, Matthewson K. Complications of baclofen overdosage. Postgrad Med J 1980; 56: 865–867.
29. Bensmail D, Quera Salva MA, Roche N, et al. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity. Neurology 2006; 67: 1432–1436.
30. Buyse B, Demedts M, Meekers J, Vandegaer L, Rochette F, Kerkhofs L. Respiratory dysfunction in multiple sclerosis: a prospective analysis of 60 patients. Eur Respir J 1997; 10: 139–145.
31. Ray AD, Udhoji S, Mashtare TL, Fisher NM. A combined inspiratory and expiratory muscle training program improves respiratory muscle strength and fatigue in multiple sclerosis. Arch Phys Med Rehabil 2013; 94: 1964–1970.
32. Klefbeck B. Hamrah Nedjad J. Effect of inspiratory muscle training in patients with multiple sclerosis. Arch Phys Med Rehabil 2003; 84: 994–999.
33. Pfalzer L, Fry D. Effects of a 10-week inspiratory muscle training program on lower-extremity mobility in people with multiple sclerosis: a randomized controlled trial. Int J MS Care 2011; 13: 32–42.
34. Carvalho SR, Alvarenga Filho H, Papais-Alvarenga RM, Chacur FH, Dias RM. Is it useful to perform carbon monoxide diffusion capacity and respiratory muscle function tests in patients with multiple sclerosis without disability? Respirology 2012; 17: 869–875.
35. Hughes JMB, Pride NB. Examination of the carbon monoxide diffusing capacity (DlCO) in relation to its Kco and Va components. Am J Respir Crit Care Med 2012; 186: 132–139.
36. Motl RW, Pilutti LA. The benefits of exercise training in multiple sclerosis. Nat Rev Neurol 2012; 8: 487–497.
37. Westerdahl E, Wittrin A, Kånåhols M, Gunnarsson M, Nilsagård Y. Deep breathing exercises with positive expiratory pressure in patients with multiple sclerosis – a randomized controlled trial. Clin Respir J 2016; 10: 698–706.